Stryker (SYK)
AI-powered earnings call analysis for Stryker. Get insights from quarterly earnings reports with our AI-generated podcast. Educational content only - not investment advice.
Subscribe
Subscribe
Get Episode Notifications
Get an email when new Stryker earnings episodes are released.
Next Episode
Stryker earnings call scheduled for Jan 28, 2027 (after market close)
New episode expected Jan 29, 2027
Latest Episode
Q3 2026 Earnings
7:20 • 10/30/2026
All Episodes
Q3 2026 Earnings
7:20Q3 organic sales 7.7% offset by hip/knee slowdown to ~2.5%; revised FY guidance to 6.5%-7%. Completed ZuriMED deal, CMR Versius partnership. Margins expanded despite sales pressure.
Q2 2026 Earnings
6:38Stryker posted 9% organic growth, $3.69 adjusted EPS (+17.9%), and narrowed FY guidance to 8.3%-9.3% sales and $14.95-$15.10 EPS, driven by capital recovery and record Mako installations.
Q1 2026 Earnings
7:38Stryker's Q1 2026 results were materially impacted by a late-quarter cyber incident causing 2.4% organic growth and 8.5% EPS decline, yet management reaffirmed full-year guidance of 8%-9.5% sales growth and $14.90-$15.10 EPS, supported by strong product momentum including record Mako installations and recent regulatory approvals.
Q4 2025 Earnings
7:34AI-generated analysis of SYK's Q4 2025 earnings call.
